Monoclonal antibody against CGRP (TEV-48125) for preventive treatment of episodic cluster headache: a phase II randomized clinical trial protocol. Principles and Practice of Clinical Research, [S. l.], v. 4, n. 1, p. 14–20, 2018. Disponível em: https://journal.ppcr.org/index.php/ppcrjournal/article/view/53.. Acesso em: 7 may. 2024.